13D/13G Filings - Nantahala Capital Management, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, ...13, 14, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Titan Machinery Inc.
TITN
Nantahala Capital Management, LLC 1,625,276
7.027%
1,625,276increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Benitec Biopharma Inc.
BNTC
Nantahala Capital Management, LLC 1,038,371
9.654%
1,038,371increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Unicycive Therapeutics, Inc.
UNCY
Nantahala Capital Management, LLC 10,159,349
9.990%
6,683,636increase
(+192.30%)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G uniQure N.V.
QURE
Nantahala Capital Management, LLC 2,982,013
6.123%
-176,014decrease
(-5.57%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Verastem, Inc.
VSTM
Nantahala Capital Management, LLC 4,052,204
9.990%
4,052,204increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G VistaGen Therapeutics, Inc.
VTGN
Nantahala Capital Management, LLC 2,834,336
9.990%
36,748increase
(+1.31%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Xtant Medical Holdings, Inc.
XTNT
Nantahala Capital Management, LLC 11,394,000
8.214%
11,394,000increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Zevra Therapeutics, Inc.
ZVRA
Nantahala Capital Management, LLC 2,924,021
5.557%
470,616increase
(+19.18%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Viemed Healthcare, Inc.
VMD
Nantahala Capital Management, LLC 1,135,122
2.924%
1,135,122increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G Bioventus Inc.
BVS
Nantahala Capital Management, LLC 4,350,870
6.686%
-1,626,601decrease
(-27.21%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G BlackSky Technology Inc.
BKSY
Nantahala Capital Management, LLC 2,450,000
8.562%
2,450,000increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Cellectar Biosciences, Inc.
CLRB
Nantahala Capital Management, LLC 3,677,739
9.990%
447,836increase
(+13.87%)
Filing
History
2024-11-14
4:53 pm
Purchase
2024-09-30 13G eHealth, Inc.
EHTH
Nantahala Capital Management, LLC 1,911,821
6.502%
1,911,821increase
(New Position)
Filing
History
2024-11-14
4:53 pm
Sale
2024-09-30 13G Codexis, Inc.
CDXS
Nantahala Capital Management, LLC 2,967,808
4.263%
-1,625,095decrease
(-35.38%)
Filing
History
2024-11-13
5:30 pm
Purchase
2024-09-30 13G BiomX Inc.
PHGE
Nantahala Capital Management, LLC 1,794,141
9.990%
1,794,141increase
(New Position)
Filing
History
2024-11-06
4:31 pm
Purchase
2024-11-06 13D Evoke Pharma, Inc.
EVOK
Nantahala Capital Management, LLC 254,632
15.990%
169,946increase
(+200.68%)
Filing
History
2024-11-05
4:32 pm
Purchase
2024-10-31 13G Eagle Pharmaceuticals, Inc.
EGRX
Nantahala Capital Management, LLC 3,945,209
30.400%
1,983,139increase
(+101.07%)
Filing
History
2024-10-01
4:53 pm
Unchanged
2024-09-27 13D Evoke Pharma, Inc.
EVOK
Nantahala Capital Management, LLC 84,686
10.000%
0
(Unchanged)
Filing
History
2024-09-24
4:31 pm
Purchase
2024-09-19 13D America's Car-Mart, Inc.
CRMT
Nantahala Capital Management, LLC 544,686
6.700%
544,686increase
(New Position)
Filing
History
2024-09-20
7:28 pm
Purchase
2024-09-20 13D Evoke Pharma, Inc.
EVOK
Nantahala Capital Management, LLC 84,686
10.000%
84,686increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, ...13, 14, Next